In a guideline issued by the U.S. Cystic Fibrosis Foundation and published online April 2 in the International Journal of ...

Dr. Michael Welsh, a longtime University of Iowa physician-scientist, has been named a 2025 recipient of the prestigious ...

Key Takeaways Current newborn screening for cystic fibrosis favors white children over those from other backgroundsCF genetic ...

Vertex Pharmaceuticals earned well-deserved kudos after Dr. Paul Negulescu snagged the 2025 Canada Gairdner International ...

Canada Gairdner Awards recognize the world’s most accomplished researchers whose work is improving our understanding of human ...

Emporia State University hosts Laps 4 Landon, a free community event dedicated to raising awareness for people who battle ...

While many of the patients that come through the UCSF Fresno Cystic Fibrosis Center are still young, they have transitioned ...

Gene therapy for cystic fibrosis is advancing fast. Explore key biotech players, clinical progress, and its potential to ...

The new approval makes the regimen an option for around 4,000 patients in the EU who have at least one non-class I CFTR mutation.

Vertex Pharmaceuticals (VRTX) announced that the European Commission has granted regulatory approval for a label expansion of KAFTRIO in a ...